Resumen
Reward Deficiency Syndrome (RDS) is an umbrella term for all drug and nondrug addictive behaviors, due to a dopamine deficiency, “hypodopaminergia.” There is an opioid-overdose epidemic in the USA, which may result in or worsen RDS. A paradigm shift is needed to combat a system that is not working. This shift involves the recognition of dopamine homeostasis as the ultimate treatment of RDS via precision, genetically guided KB220 variants, called Precision Behavioral Management (PBM). Recognition of RDS as an endophenotype and an umbrella term in the future DSM 6, following the Research Domain Criteria (RDoC), would assist in shifting this paradigm.
| Idioma original | English (US) |
|---|---|
| Título de la publicación alojada | The Cambridge Handbook of Substance and Behavioral Addictions |
| Editorial | Cambridge University Press |
| Páginas | 297-306 |
| Número de páginas | 10 |
| ISBN (versión digital) | 9781108632591 |
| ISBN (versión impresa) | 9781108427166 |
| DOI | |
| Estado | Published - ene 1 2020 |
ASJC Scopus subject areas
- General Psychology
- General Social Sciences
- General Medicine
Huella
Profundice en los temas de investigación de 'Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS